These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7191260)

  • 1. [Plasma levels and renal excretion of [3H]-codeine phosphate in humans receiving tablets or depot capsules (author's transl)].
    Sinterhauf K; Bechtel WD
    Arzneimittelforschung; 1980; 30(6):1012-5. PubMed ID: 7191260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relative bioavailability of paracetamol from tablets and suppositories as well as of paracetamol and codeine in a combination tablet].
    Klein G; Barkworth MF; Birkenfeld A; Dyde CJ; Rehm KD; Töberich H; Cierpka H
    Arzneimittelforschung; 1986 Mar; 36(3):496-9. PubMed ID: 3518729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
    Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
    Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics and relative bioavailability of KC-404 sustained release tablets in healthy volunteers].
    Li T; Pang Y; Wang Z; Jia Y; Cheng Q; Sun J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):541-3. PubMed ID: 12910715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The bioavailability of combination preparations of acetylsalicylic acid and codeine phosphate].
    Spahn H; Altmayer P; Cattarius-Korb S; Krüger B; Lang E; Mutschler E; Sörgel F
    Arzneimittelforschung; 1985; 35(6):973-6. PubMed ID: 4026924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biopharmaceutic properties of slow-release codeine phosphate. Drug release from ion exchangers in vitro and in vivo].
    Wildfeuer A; Pfaff G; Lach P
    Arzneimittelforschung; 1994 Jun; 44(6):758-61. PubMed ID: 8053976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saquinavir 500 mg film-coated tablets demonstrate bioequivalence to saquinavir 200 mg hard capsules when boosted with twice-daily ritonavir in healthy volunteers.
    Bittner B; Riek M; Holmes B; Grange S
    Antivir Ther; 2005; 10(7):803-10. PubMed ID: 16312177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma levels, renal excretion and metabolism of orciprenaline after administration in sustained-release form (author's transl)].
    Gilfrich HJ; Ober KF; Förster HJ; Rominger KL
    Arzneimittelforschung; 1979; 29(6):967-70. PubMed ID: 582794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and drug input characteristics for a diclofenac-codeine phosphate combination following oral and rectal administration.
    Hanses A; Spahn-Langguth H; Meiss F; Mutschler E
    Arzneimittelforschung; 1996 Jan; 46(1):57-63. PubMed ID: 8821519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and relative bioavailability of lomefloxacin preparations in 10 healthy Chinese volunteers.
    Diao Y; Lu J; Li L; Zhu XD; Ji G; Wang EH
    Zhongguo Yao Li Xue Bao; 1993 May; 14(3):247-9. PubMed ID: 8237402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dextromethorphan and codeine: comparison of plasma kinetics and antitussive effects.
    Aylward M; Maddock J; Davies DE; Protheroe DA; Leideman T
    Eur J Respir Dis; 1984 May; 65(4):283-91. PubMed ID: 6539224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of codeine and chlorphenamine in serum by thin-layer chromatography. In vivo demonstration of the retard effect of codeine and chlorphenamine in depot soft-gelatine capsules].
    Fischer H; Eulenhöfer HG; Kraft R
    Arzneimittelforschung; 1971 Nov; 21(11):1692-6. PubMed ID: 5172413
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacokinetics and relative bioavailability of a nitroglycerin ointment formulation (author's transl)].
    Maier-Lenz H; Ringwelski L; Windorfer A
    Arzneimittelforschung; 1980; 30(2):320-4. PubMed ID: 6769443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma level and renal excretion of [3H] codeine phosphate in man and in the dog.
    Bechtel WD; Sinterhauf K
    Arzneimittelforschung; 1978; 28(2):308-11. PubMed ID: 580399
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bioavailability and tolerance of xanthinol nicotinate depot preparations. Comparison of a conventional 500 mg xanthinol nicotinate depot tablet with new 500 mg and 1 g depot tablets].
    von Schrader HW; Buscher G; Dierdorf D; Freytag A; Mügge H; Wolf D
    Arzneimittelforschung; 1985; 35(9):1468-72. PubMed ID: 4084347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.